Literature DB >> 9973233

Differential effects of chemical sympathectomy on expression and activity of tyrosine hydroxylase and levels of catecholamines and DOPA in peripheral tissues of rats.

M Kawamura1, J P Schwartz, T Nomura, I J Kopin, D S Goldstein, T T Huynh, D R Hooper, J Harvey-White, G Eisenhofer.   

Abstract

Tyrosine hydroxylase (TH) mRNA and activity and concentrations of 3,4-dihydroxyphenylalanine (DOPA) and catecholamines were examined as markers of sympathetic innervation and catecholamine synthesis in peripheral tissues of sympathectomized and intact rats. Chemical sympathectomy with 6-hydroxydopamine (6-OHDA) markedly decreased norepinephrine and to a generally lesser extent TH activities and dopamine in most peripheral tissues (stomach, lung, testis, duodenum, pancreas, salivary gland, spleen, heart, kidney, thymus). Superior cervical ganglia, adrenals and descending aorta were unaffected and vas deferens showed a large 92% decrease in norepinephrine, but only a small 38% decrease in TH activity after 6-OHDA. Presence of chromaffin cells or neuronal cell bodies in these latter tissues, indicated by consistent expression of TH mRNA, explained the relative resistance of these tissues to 6-OHDA. Stomach also showed consistent expression of TH mRNA before, but not after 6-OHDA, suggesting that catecholamine synthesizing cells in gastric tissue are sensitive to the toxic effects of 6-OHDA. Tissue concentrations of DOPA were mainly unaffected by 6-OHDA, indicating that much of the DOPA in peripheral tissues is synthesized independently of local TH or sympathetic innervation. The differential effects of chemical sympathectomy on tissue catecholamines, DOPA, TH mRNA and TH activity demonstrate that these variables are not simple markers of sympathetic innervation or catecholamine synthesis. Other factors, including presence of neuronal cell bodies, parenchymal chromaffin cells, non-neuronal sites of catecholamine synthesis and alternative sources of tissue DOPA, must also be considered when tissue catecholamines, DOPA and TH are examined as markers of sympathetic innervation and local catecholamine synthesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973233     DOI: 10.1023/a:1020919828028

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  22 in total

1.  The function of the organs of Zuckerkandl.

Authors:  G B WEST; D M SHEPHERD; R B HUNTER; A R MACGREGOR
Journal:  Clin Sci       Date:  1953-11       Impact factor: 6.124

2.  Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

Authors:  G Eisenhofer; D S Goldstein; R Stull; H R Keiser; T Sunderland; D L Murphy; I J Kopin
Journal:  Clin Chem       Date:  1986-11       Impact factor: 8.327

3.  Transfer of DOPA from the sympatho-adrenal system to the pancreas, liver and kidney via the blood circulation.

Authors:  N E Andén; M Grabowska-Andén; J Schwieler
Journal:  Acta Physiol Scand       Date:  1989-05

Review 4.  Pharmacological actions of 6-hydroxydopamine.

Authors:  R M Kostrzewa; D M Jacobowitz
Journal:  Pharmacol Rev       Date:  1974-09       Impact factor: 25.468

5.  Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine.

Authors:  H Thoenen; J P Tranzer
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

6.  Trans-synaptic induction of adrenal tyrosine hydroxylase.

Authors:  H Thoenen; R A Mueller; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1969-10       Impact factor: 4.030

7.  The organ of Zuckerkandl of the newborn rat and its postnatal involution.

Authors:  M R De Gallardo; F Freire; J H Tramezzani
Journal:  Acta Physiol Lat Am       Date:  1974

8.  Stimulation of nerve growth factor mRNA content in C6 glioma cells by a beta-adrenergic receptor and by cyclic AMP.

Authors:  J P Schwartz
Journal:  Glia       Date:  1988       Impact factor: 7.452

9.  Central and peripheral changes in catecholamine-synthesizing enzyme activities after systemic administration of the neurotoxin DSP-4.

Authors:  R Féty; V Misère; L Lambàs-Señas; B Renaud
Journal:  Eur J Pharmacol       Date:  1986-05-13       Impact factor: 4.432

10.  DOPA, norepinephrine, and dopamine in rat tissues: no effect of sympathectomy on muscle DOPA.

Authors:  E Eldrup; E A Richter; N J Christensen
Journal:  Am J Physiol       Date:  1989-02
View more
  8 in total

1.  Modeling of chronic selective inhibition of noradrenaline synthesis in the brain of neonatal rats.

Authors:  Y O Zubova; N S Bondarenko; A Ja Sapronova; M V Ugrumov
Journal:  Dokl Biochem Biophys       Date:  2015-05-05       Impact factor: 0.788

Review 2.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

3.  Catecholamine-synthesizing enzymes in the adult and prenatal human testis.

Authors:  Michail S Davidoff; Hendrik Ungefroren; Ralf Middendorff; Yvetta Koeva; Mariana Bakalska; Nina Atanassova; Adolf F Holstein; Davor Jezek; Wolfgang Pusch; Dieter Müller
Journal:  Histochem Cell Biol       Date:  2005-10-28       Impact factor: 4.304

4.  Determination of endogenous norepinephrine levels in different chambers of the rat heart by capillary electrophoresis coupled with amperometric detection.

Authors:  Martin Novotny; Veronika Quaiserová-Mocko; Erica A Wehrwein; David L Kreulen; Greg M Swain
Journal:  J Neurosci Methods       Date:  2007-02-16       Impact factor: 2.390

5.  Effect of stellate ganglionectomy on basal cardiovascular function and responses to beta1-adrenoceptor blockade in the rat.

Authors:  Misa Yoshimoto; Erica A Wehrwein; Martin Novotny; Greg M Swain; David L Kreulen; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-17       Impact factor: 4.733

6.  Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys.

Authors:  Valerie Joers; Kailie Seneczko; Nichole C Goecks; Timothy J Kamp; Timothy A Hacker; Kevin G Brunner; Jonathan W Engle; Todd E Barnhart; R Jerome Nickles; James E Holden; Marina E Emborg
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

7.  Gastrointestinal Dopamine in Inflammatory Bowel Diseases: A Systematic Review.

Authors:  Magdalena Kurnik-Łucka; Paweł Pasieka; Patrycja Łączak; Marcin Wojnarski; Michał Jurczyk; Krzysztof Gil
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

8.  Cardiac Dysregulation and Myocardial Injury in a 6-Hydroxydopamine-Induced Rat Model of Sympathetic Denervation.

Authors:  Yue-Hua Jiang; Ping Jiang; Jin-Long Yang; Du-Fang Ma; Hai-Qing Lin; Wen-Ge Su; Zhen Wang; Xiao Li
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.